Glycoregimmune, Inc.
Records under this name other than patents Glycoregimmune, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,143,668 | Hydroxy-substituted amino and ammonium derivatives and their medical use Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,829,506 | Amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,453,642 | Oxygenated amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,564,895 | Hydroxy-substituted amino and ammonium derivatives and their medical use Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,815,195 | Oxygenated amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,949,996 | Prevention and treatment of inflammatory conditions Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,925,886 | Prevention and treatment of inflammatory conditions Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,660,309 | Prevention and Treatment of Inflammatory Conditions Formerly held In force · Low confidence | In force | Low confidence | |
| US 10,952,977 | Hydroxy-substituted amino and ammonium derivatives and their medical use Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,573,886 | Hydroxy-substituted amino and ammonium derivatives and their medical use Formerly held In force (reinstated) · USPTO record | In force (reinstated) | USPTO record |